{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:11:52Z","timestamp":1780647112407,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"DOI":"10.7759\/cureus.110281","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:49:11Z","timestamp":1780645751000},"source":"Crossref","is-referenced-by-count":0,"title":["The Use of Naltrexone to Successfully Treat Severe Hailey-Hailey Disease"],"prefix":"10.7759","author":[{"given":"Fatemeh","family":"Mehrabian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaz","family":"Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rand","family":"Hawari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1939.01480220064005","article-title":"Familial benign chronic pemphigus","volume":"39","author":"Hailey H","year":"1939","unstructured":"Hailey H, Hailey H. Familial benign chronic pemphigus. Arch Derm Syphilol. 1939, 39:679-685. 10.1001\/archderm.1939.01480220064005","journal-title":"Arch Derm Syphilol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/71701","article-title":"Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease","volume":"24","author":"Hu Z","year":"2000","unstructured":"Hu Z, Bonifas JM, Beech J, et al.. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet. 2000, 24:61-65. 10.1038\/71701","journal-title":"Nat Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/9.7.1131","article-title":"Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump","volume":"9","author":"Sudbrak R","year":"2000","unstructured":"Sudbrak R, Brown J, Dobson-Stone C, et al.. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet. 2000, 9:1131-1140. 10.1093\/hmg\/9.7.1131","journal-title":"Hum Mol Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00658.x","article-title":"Hailey-Hailey disease: the clinical features, response to treatment and prognosis","volume":"126","author":"Burge SM","year":"1992","unstructured":"Burge SM. Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol. 1992, 126:275-282. 10.1111\/j.1365-2133.1992.tb00658.x","journal-title":"Br J Dermatol"},{"key":"ref5","article-title":"Benign Familial Pemphigus (Hailey-Hailey Disease)","author":"Konstantinou MP","year":"2023","unstructured":"Konstantinou MP, Krasagakis K. Benign Familial Pemphigus (Hailey-Hailey Disease). StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/00015550410025462","article-title":"Severe impairment of quality of life in Hailey-Hailey disease","volume":"85","author":"Gisondi P","year":"2005","unstructured":"Gisondi P, Sampogna F, Annessi G, Girolomoni G, Abeni D. Severe impairment of quality of life in Hailey-Hailey disease. Acta Derm Venereol. 2005, 85:132-135. 10.1080\/00015550410025462","journal-title":"Acta Derm Venereol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00477-z","article-title":"Hailey-Hailey disease: an update review with a focus on treatment data","volume":"21","author":"Ben Lagha I","year":"2020","unstructured":"Ben Lagha I, Ashack K, Khachemoune A. Hailey-Hailey disease: an update review with a focus on treatment data. Am J Clin Dermatol. 2020, 21:49-68. 10.1007\/s40257-019-00477-z","journal-title":"Am J Clin Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.2445","article-title":"Low-dose naltrexone treatment of familial benign pemphigus (Hailey-Hailey disease)","volume":"153","author":"Ibrahim O","year":"2017","unstructured":"Ibrahim O, Hogan SR, Vij A, Fernandez AP. Low-dose naltrexone treatment of familial benign pemphigus (Hailey-Hailey disease). JAMA Dermatol. 2017, 153:1015-1017. 10.1001\/jamadermatol.2017.2445","journal-title":"JAMA Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.2446","article-title":"Treatment of Hailey-Hailey disease with low-dose naltrexone","volume":"153","author":"Albers LN","year":"2017","unstructured":"Albers LN, Arbiser JL, Feldman RJ. Treatment of Hailey-Hailey disease with low-dose naltrexone. JAMA Dermatol. 2017, 153:1018-1020. 10.1001\/jamadermatol.2017.2446","journal-title":"JAMA Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.07.002","article-title":"Generalized familial benign chronic pemphigus (Hailey-Hailey disease) treated successfully with low-dose naltrexone","volume":"4","author":"Kollman N","year":"2018","unstructured":"Kollman N, Bass J. Generalized familial benign chronic pemphigus (Hailey-Hailey disease) treated successfully with low-dose naltrexone. JAAD Case Rep. 2018, 4:725-727. 10.1016\/j.jdcr.2018.07.002","journal-title":"JAAD Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.06.022","article-title":"Hailey-Hailey disease treated successfully with naltrexone and magnesium","volume":"5","author":"Alajmi A","year":"2019","unstructured":"Alajmi A, Jfri A, Lovett A. Hailey-Hailey disease treated successfully with naltrexone and magnesium. JAAD Case Rep. 2019, 5:760-762. 10.1016\/j.jdcr.2019.06.022","journal-title":"JAAD Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16045","article-title":"Low-dose naltrexone: a novel treatment for Hailey-Hailey disease","volume":"178","author":"Campbell V","year":"2018","unstructured":"Campbell V, McGrath C, Corry A. Low-dose naltrexone: a novel treatment for Hailey-Hailey disease. Br J Dermatol. 2018, 178:1196-1198. 10.1111\/bjd.16045","journal-title":"Br J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.04.024","article-title":"Low-dose naltrexone therapy in benign chronic pemphigus (Hailey-Hailey disease): a case series","volume":"81","author":"Riquelme-Mc LC","year":"2019","unstructured":"Riquelme-Mc LC, Riera-Monroig J, Morgado-Carrasco D, Giavedoni P, Podlipnik S, Iranzo P, Mascar\u00f3 JM Jr. Low-dose naltrexone therapy in benign chronic pemphigus (Hailey-Hailey disease): a case series. J Am Acad Dermatol. 2019, 81:644-646. 10.1016\/j.jaad.2019.04.024","journal-title":"J Am Acad Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.12.031","article-title":"The uses of naltrexone in dermatologic conditions","volume":"80","author":"Lee B","year":"2019","unstructured":"Lee B, Elston DM. The uses of naltrexone in dermatologic conditions. J Am Acad Dermatol. 2019, 80:1746-1752. 10.1016\/j.jaad.2018.12.031","journal-title":"J Am Acad Dermatol"},{"key":"ref15","article-title":"","author":"Singh D","year":"2026","unstructured":"Singh D, Saadabadi A. Naltrexone. StatPearls Publishing, Treasure Island, FL; 2026. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534811\/."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00809","article-title":"Naltrexone inhibits IL-6 and TNF\u03b1 production in human immune cell subsets following stimulation with ligands for intracellular toll-like receptors","volume":"8","author":"Cant R","year":"2017","unstructured":"Cant R, Dalgleish AG, Allen RL. Naltrexone inhibits IL-6 and TNF\u03b1 production in human immune cell subsets following stimulation with ligands for intracellular toll-like receptors. Front Immunol. 2017, 8:809. 10.3389\/fimmu.2017.00809","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5113","article-title":"Variable response to naltrexone in patients with Hailey-Hailey disease","volume":"154","author":"Cao S","year":"2018","unstructured":"Cao S, Lilly E, Chen ST. Variable response to naltrexone in patients with Hailey-Hailey disease. JAMA Dermatol. 2018, 154:362-363. 10.1001\/jamadermatol.2017.5113","journal-title":"JAMA Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_51_19","article-title":"Comparative study of clinical and dermoscopic features in nail psoriasis","volume":"11","author":"Wanniang N","year":"2020","unstructured":"Wanniang N, Navya A, Pai V, Ghodge R. Comparative study of clinical and dermoscopic features in nail psoriasis. Indian Dermatol Online J. 2020, 11:35-40. 10.4103\/idoj.IDOJ_51_19","journal-title":"Indian Dermatol Online J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X20984121","article-title":"Improvement in Hailey-Hailey disease with a combination of low-dose naltrexone and oral magnesium chloride: a case report","volume":"8","author":"Lim D","year":"2020","unstructured":"Lim D, Belisle A, Davar S. Improvement in Hailey-Hailey disease with a combination of low-dose naltrexone and oral magnesium chloride: a case report. SAGE Open Med Case Rep. 2020, 8:2050313X20984121. 10.1177\/2050313X20984121","journal-title":"SAGE Open Med Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18861","article-title":"Improvement of Hailey-Hailey disease with low-dose naltrexone","volume":"182","author":"Jasans-Barcel\u00f3 M","year":"2020","unstructured":"Jasans-Barcel\u00f3 M, Curman P, Hagstr\u00f6mer L, Wikstrom JD, Sairafi D. Improvement of Hailey-Hailey disease with low-dose naltrexone. Br J Dermatol. 2020, 182:1500-1502. 10.1111\/bjd.18861","journal-title":"Br J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/493751-the-use-of-naltrexone-to-successfully-treat-severe-hailey-hailey-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:49:11Z","timestamp":1780645751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/493751-the-use-of-naltrexone-to-successfully-treat-severe-hailey-hailey-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.110281","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}